Gene Symbol | Gene ID | Gene Info |
---|---|---|
LEF1
|
ENSG00000138795.5 | lymphoid enhancer binding factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_109044873_109045024 | LEF1 | 42509 | 0.157348 | 0.98 | 2.5e-06 | Click! |
chr4_109029927_109030290 | LEF1 | 57349 | 0.123695 | 0.97 | 2.1e-05 | Click! |
chr4_109057827_109057978 | LEF1 | 29555 | 0.188088 | 0.96 | 3.0e-05 | Click! |
chr4_109055473_109055665 | LEF1 | 31888 | 0.182664 | 0.96 | 3.9e-05 | Click! |
chr4_109027301_109027793 | LEF1 | 59910 | 0.118386 | 0.96 | 4.2e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_39163244_39163586 | 0.98 |
FYB |
FYN binding protein |
39714 |
0.18 |
chr12_95383197_95383469 | 0.91 |
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 |
14143 |
0.23 |
chr7_37349133_37349657 | 0.87 |
ELMO1 |
engulfment and cell motility 1 |
32972 |
0.18 |
chr19_10254387_10254800 | 0.76 |
EIF3G |
eukaryotic translation initiation factor 3, subunit G |
24015 |
0.07 |
chr3_32344273_32344503 | 0.75 |
ENSG00000207857 |
. |
43168 |
0.14 |
chr1_198503645_198504115 | 0.69 |
ATP6V1G3 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
5924 |
0.32 |
chr13_114912317_114912766 | 0.69 |
RASA3 |
RAS p21 protein activator 3 |
14455 |
0.21 |
chr11_128653079_128653231 | 0.68 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
18470 |
0.2 |
chr13_114914753_114915138 | 0.67 |
RASA3 |
RAS p21 protein activator 3 |
16859 |
0.2 |
chr4_109029927_109030290 | 0.67 |
LEF1 |
lymphoid enhancer-binding factor 1 |
57349 |
0.12 |
chr13_52395086_52395622 | 0.66 |
RP11-327P2.5 |
|
16921 |
0.18 |
chr6_2857051_2857287 | 0.65 |
ENSG00000266750 |
. |
2828 |
0.25 |
chr1_160598519_160598922 | 0.63 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
18091 |
0.14 |
chr20_3134599_3134750 | 0.62 |
UBOX5 |
U-box domain containing 5 |
5848 |
0.12 |
chr17_25545440_25545735 | 0.62 |
ENSG00000263583 |
. |
75435 |
0.11 |
chr15_70772794_70773262 | 0.61 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
221592 |
0.02 |
chr12_96501965_96502243 | 0.60 |
ENSG00000266889 |
. |
6077 |
0.22 |
chr6_112014068_112014237 | 0.60 |
FYN |
FYN oncogene related to SRC, FGR, YES |
27113 |
0.18 |
chr6_130543838_130543989 | 0.59 |
SAMD3 |
sterile alpha motif domain containing 3 |
45 |
0.99 |
chr17_46515212_46515468 | 0.59 |
SKAP1 |
src kinase associated phosphoprotein 1 |
7759 |
0.15 |
chr1_121258953_121259201 | 0.59 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
323140 |
0.01 |
chr15_77454937_77455088 | 0.58 |
TSPAN3 |
tetraspanin 3 |
78686 |
0.09 |
chr18_60979198_60979416 | 0.58 |
RP11-28F1.2 |
|
2008 |
0.3 |
chr5_35833459_35833610 | 0.58 |
CTD-2113L7.1 |
|
6414 |
0.21 |
chr6_143229651_143229867 | 0.58 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
36579 |
0.2 |
chr5_175460701_175460852 | 0.58 |
THOC3 |
THO complex 3 |
907 |
0.51 |
chr1_154438581_154439022 | 0.57 |
RP11-350G8.9 |
|
13687 |
0.12 |
chrX_19761943_19762207 | 0.57 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
2454 |
0.43 |
chr4_109038555_109038892 | 0.57 |
LEF1 |
lymphoid enhancer-binding factor 1 |
48734 |
0.14 |
chr1_186258649_186258839 | 0.56 |
PRG4 |
proteoglycan 4 |
6661 |
0.2 |
chr1_7990434_7990597 | 0.56 |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
4645 |
0.21 |
chr2_231322568_231322719 | 0.56 |
SP100 |
SP100 nuclear antigen |
4507 |
0.27 |
chr18_56809913_56810064 | 0.55 |
SEC11C |
SEC11 homolog C (S. cerevisiae) |
2857 |
0.35 |
chr12_69285926_69286077 | 0.55 |
ENSG00000252770 |
. |
19700 |
0.15 |
chr18_56326833_56326984 | 0.55 |
MALT1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
11710 |
0.14 |
chr1_65343327_65343799 | 0.54 |
JAK1 |
Janus kinase 1 |
88624 |
0.08 |
chr20_49543758_49543983 | 0.54 |
ADNP |
activity-dependent neuroprotector homeobox |
1483 |
0.3 |
chr3_118668002_118668153 | 0.54 |
IGSF11-AS1 |
IGSF11 antisense RNA 1 |
6157 |
0.29 |
chr2_32160623_32160774 | 0.54 |
ENSG00000221326 |
. |
15680 |
0.19 |
chr6_144696611_144696823 | 0.54 |
UTRN |
utrophin |
31480 |
0.21 |
chr13_95159605_95159756 | 0.53 |
DCT |
dopachrome tautomerase |
27744 |
0.19 |
chr10_11273304_11273484 | 0.53 |
RP3-323N1.2 |
|
60055 |
0.12 |
chr18_60960927_60961165 | 0.53 |
RP11-28F1.2 |
|
20269 |
0.17 |
chr5_169760742_169761397 | 0.53 |
KCNIP1 |
Kv channel interacting protein 1 |
19422 |
0.18 |
chr6_128133123_128133274 | 0.53 |
THEMIS |
thymocyte selection associated |
88905 |
0.1 |
chr5_57754783_57754943 | 0.52 |
PLK2 |
polo-like kinase 2 |
1224 |
0.53 |
chr17_74195218_74195369 | 0.52 |
RNF157 |
ring finger protein 157 |
32130 |
0.11 |
chr2_136809392_136809630 | 0.52 |
AC093391.2 |
|
39476 |
0.17 |
chr16_22374784_22374935 | 0.52 |
RP11-21M24.3 |
|
1583 |
0.31 |
chr10_14581358_14581509 | 0.51 |
FAM107B |
family with sequence similarity 107, member B |
6724 |
0.26 |
chr1_101706352_101706538 | 0.51 |
RP4-575N6.5 |
|
2269 |
0.24 |
chr13_78274408_78274775 | 0.51 |
SLAIN1 |
SLAIN motif family, member 1 |
1574 |
0.38 |
chr15_38976681_38977159 | 0.51 |
C15orf53 |
chromosome 15 open reading frame 53 |
11879 |
0.28 |
chr2_175353345_175353496 | 0.51 |
GPR155 |
G protein-coupled receptor 155 |
1598 |
0.4 |
chr19_5950706_5950998 | 0.50 |
RANBP3 |
RAN binding protein 3 |
27238 |
0.08 |
chr21_36416088_36416341 | 0.50 |
RUNX1 |
runt-related transcription factor 1 |
5248 |
0.35 |
chr15_58914890_58915041 | 0.50 |
ENSG00000239100 |
. |
22531 |
0.17 |
chr3_107697956_107698544 | 0.50 |
CD47 |
CD47 molecule |
78958 |
0.11 |
chr10_126404723_126405025 | 0.50 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
12121 |
0.18 |
chr17_40636532_40636792 | 0.50 |
ENSG00000264314 |
. |
10129 |
0.09 |
chr2_43413623_43414100 | 0.50 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
39887 |
0.17 |
chrX_123120182_123120333 | 0.50 |
STAG2 |
stromal antigen 2 |
23237 |
0.22 |
chr4_122110306_122110568 | 0.49 |
ENSG00000252183 |
. |
3621 |
0.28 |
chr2_231361368_231362080 | 0.49 |
SP100 |
SP100 nuclear antigen |
7253 |
0.21 |
chr1_76760906_76761057 | 0.49 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
220577 |
0.02 |
chr15_58001915_58002066 | 0.49 |
POLR2M |
polymerase (RNA) II (DNA directed) polypeptide M |
3067 |
0.36 |
chr14_61850578_61851088 | 0.49 |
PRKCH |
protein kinase C, eta |
6579 |
0.26 |
chr2_101260921_101261203 | 0.49 |
ENSG00000265839 |
. |
43734 |
0.14 |
chr13_49512520_49512861 | 0.49 |
ENSG00000265585 |
. |
8342 |
0.23 |
chr14_22995523_22996056 | 0.49 |
TRAJ15 |
T cell receptor alpha joining 15 |
2791 |
0.16 |
chr10_11231925_11232076 | 0.49 |
RP3-323N1.2 |
|
18661 |
0.21 |
chr13_109062811_109063048 | 0.49 |
ENSG00000223177 |
. |
109250 |
0.07 |
chr2_44901800_44902050 | 0.49 |
ENSG00000252896 |
. |
107344 |
0.07 |
chr15_52778905_52779098 | 0.49 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
42037 |
0.16 |
chr7_100814110_100814261 | 0.49 |
VGF |
VGF nerve growth factor inducible |
5311 |
0.1 |
chr14_98650836_98650996 | 0.49 |
ENSG00000222066 |
. |
147171 |
0.05 |
chr18_29679004_29679408 | 0.49 |
ENSG00000238982 |
. |
4739 |
0.14 |
chr1_198617796_198617982 | 0.49 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
9597 |
0.24 |
chr6_160203746_160203924 | 0.49 |
ENSG00000207392 |
. |
2422 |
0.16 |
chr2_198101522_198101823 | 0.48 |
ANKRD44 |
ankyrin repeat domain 44 |
38910 |
0.14 |
chr6_167536441_167536973 | 0.48 |
CCR6 |
chemokine (C-C motif) receptor 6 |
448 |
0.83 |
chr3_188862026_188862244 | 0.48 |
TPRG1 |
tumor protein p63 regulated 1 |
27628 |
0.25 |
chr5_67555215_67555697 | 0.48 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
19730 |
0.25 |
chr5_55778006_55778314 | 0.48 |
CTC-236F12.4 |
Uncharacterized protein |
564 |
0.79 |
chr2_106778172_106778934 | 0.48 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
1472 |
0.48 |
chr8_134071429_134072001 | 0.48 |
SLA |
Src-like-adaptor |
888 |
0.68 |
chr1_236447358_236447555 | 0.47 |
ERO1LB |
ERO1-like beta (S. cerevisiae) |
2137 |
0.29 |
chr2_103035509_103035977 | 0.47 |
IL18RAP |
interleukin 18 receptor accessory protein |
162 |
0.94 |
chr6_52849862_52850203 | 0.47 |
ENSG00000252106 |
. |
5979 |
0.14 |
chr12_6570561_6570923 | 0.47 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
9069 |
0.09 |
chr6_149815060_149815270 | 0.47 |
ZC3H12D |
zinc finger CCCH-type containing 12D |
8968 |
0.15 |
chr15_73032253_73032404 | 0.47 |
BBS4 |
Bardet-Biedl syndrome 4 |
8305 |
0.17 |
chr4_99606743_99606894 | 0.47 |
RP11-1299A16.3 |
|
26763 |
0.2 |
chr3_105501258_105501409 | 0.47 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
80288 |
0.12 |
chr2_24437987_24438211 | 0.47 |
AC009228.1 |
|
849 |
0.5 |
chr1_172612946_172613385 | 0.46 |
FASLG |
Fas ligand (TNF superfamily, member 6) |
14989 |
0.23 |
chr14_71113118_71113269 | 0.46 |
TTC9 |
tetratricopeptide repeat domain 9 |
4689 |
0.24 |
chr10_120851648_120851810 | 0.46 |
EIF3A |
eukaryotic translation initiation factor 3, subunit A |
11413 |
0.13 |
chr9_4597544_4597807 | 0.46 |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
25340 |
0.19 |
chr21_19186267_19186567 | 0.46 |
C21orf91 |
chromosome 21 open reading frame 91 |
4919 |
0.23 |
chr3_31271817_31272124 | 0.46 |
ENSG00000222983 |
. |
1763 |
0.49 |
chr10_87373902_87374053 | 0.45 |
RP11-93H12.2 |
|
8827 |
0.23 |
chr10_73491368_73491519 | 0.45 |
C10orf105 |
chromosome 10 open reading frame 105 |
6138 |
0.23 |
chr1_112167121_112167315 | 0.45 |
RAP1A |
RAP1A, member of RAS oncogene family |
4449 |
0.21 |
chr13_75891307_75891494 | 0.45 |
TBC1D4 |
TBC1 domain family, member 4 |
24267 |
0.22 |
chr12_105133638_105133797 | 0.45 |
ENSG00000222579 |
. |
111885 |
0.06 |
chr3_114882840_114883134 | 0.45 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
16869 |
0.31 |
chr2_204585403_204585554 | 0.45 |
CD28 |
CD28 molecule |
14062 |
0.22 |
chr11_122951924_122952075 | 0.45 |
HSPA8 |
heat shock 70kDa protein 8 |
18061 |
0.14 |
chr2_46578248_46578673 | 0.45 |
EPAS1 |
endothelial PAS domain protein 1 |
53919 |
0.14 |
chr13_99971792_99971943 | 0.45 |
GPR183 |
G protein-coupled receptor 183 |
12208 |
0.2 |
chr9_124115505_124115778 | 0.45 |
AL161784.1 |
Uncharacterized protein |
12016 |
0.14 |
chr3_187539986_187540311 | 0.44 |
BCL6 |
B-cell CLL/lymphoma 6 |
76633 |
0.11 |
chr1_224567153_224567600 | 0.44 |
ENSG00000266618 |
. |
18637 |
0.14 |
chr6_109357211_109357383 | 0.44 |
ENSG00000199944 |
. |
23520 |
0.16 |
chr5_10446969_10447137 | 0.44 |
ROPN1L |
rhophilin associated tail protein 1-like |
5065 |
0.16 |
chr11_67111737_67112011 | 0.44 |
POLD4 |
polymerase (DNA-directed), delta 4, accessory subunit |
9111 |
0.09 |
chr2_191936002_191936213 | 0.44 |
ENSG00000231858 |
. |
49855 |
0.11 |
chr11_85468020_85468176 | 0.44 |
SYTL2 |
synaptotagmin-like 2 |
670 |
0.74 |
chr14_66313526_66313763 | 0.44 |
CTD-2014B16.3 |
Uncharacterized protein |
157597 |
0.04 |
chr17_61687614_61687765 | 0.44 |
TACO1 |
translational activator of mitochondrially encoded cytochrome c oxidase I |
9458 |
0.14 |
chr12_68197431_68197773 | 0.43 |
RP11-335O4.3 |
|
132903 |
0.05 |
chr11_14095486_14095729 | 0.43 |
ENSG00000212365 |
. |
60925 |
0.15 |
chrX_153357689_153358011 | 0.43 |
MECP2 |
methyl CpG binding protein 2 (Rett syndrome) |
4586 |
0.16 |
chr14_98689187_98689819 | 0.43 |
ENSG00000222066 |
. |
108584 |
0.07 |
chr1_169558158_169558702 | 0.43 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
2604 |
0.31 |
chr6_12126412_12126563 | 0.43 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
508 |
0.88 |
chr18_29620502_29620880 | 0.43 |
ENSG00000265063 |
. |
20261 |
0.13 |
chr14_32571246_32571446 | 0.43 |
ARHGAP5 |
Rho GTPase activating protein 5 |
23909 |
0.18 |
chr10_121237439_121237906 | 0.43 |
RGS10 |
regulator of G-protein signaling 10 |
49317 |
0.14 |
chr11_128617499_128618014 | 0.43 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
16929 |
0.2 |
chr16_30392632_30392982 | 0.43 |
SEPT1 |
septin 1 |
945 |
0.31 |
chr8_41845965_41846221 | 0.43 |
KAT6A |
K(lysine) acetyltransferase 6A |
30212 |
0.18 |
chr2_169307443_169307594 | 0.43 |
ENSG00000241074 |
. |
316 |
0.89 |
chr22_42683170_42683321 | 0.42 |
TCF20 |
transcription factor 20 (AR1) |
56377 |
0.11 |
chr3_112408721_112408872 | 0.42 |
CCDC80 |
coiled-coil domain containing 80 |
48649 |
0.15 |
chr6_143210581_143210732 | 0.42 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
52472 |
0.16 |
chr14_50511452_50511646 | 0.42 |
ENSG00000201358 |
. |
23737 |
0.14 |
chr18_20601406_20601557 | 0.42 |
ENSG00000223023 |
. |
3078 |
0.21 |
chr5_114858752_114858964 | 0.42 |
FEM1C |
fem-1 homolog c (C. elegans) |
21733 |
0.2 |
chr1_117296335_117296486 | 0.42 |
CD2 |
CD2 molecule |
597 |
0.78 |
chr3_108553144_108553369 | 0.42 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
11637 |
0.26 |
chr1_24851023_24851224 | 0.42 |
ENSG00000266551 |
. |
5081 |
0.18 |
chr1_208008841_208008992 | 0.42 |
ENSG00000203709 |
. |
33048 |
0.19 |
chr16_67620539_67620690 | 0.42 |
CTCF |
CCCTC-binding factor (zinc finger protein) |
24304 |
0.08 |
chr3_46319179_46319439 | 0.42 |
CCR3 |
chemokine (C-C motif) receptor 3 |
12690 |
0.21 |
chr17_75663314_75663598 | 0.42 |
SEPT9 |
septin 9 |
185461 |
0.03 |
chr16_28504230_28504381 | 0.41 |
CLN3 |
ceroid-lipofuscinosis, neuronal 3 |
211 |
0.88 |
chrX_17877553_17877704 | 0.41 |
RAI2 |
retinoic acid induced 2 |
1199 |
0.63 |
chr15_26092284_26092435 | 0.41 |
ENSG00000266517 |
. |
1613 |
0.38 |
chr1_153615157_153615308 | 0.41 |
CHTOP |
chromatin target of PRMT1 |
4414 |
0.09 |
chr10_112689056_112689207 | 0.41 |
SHOC2 |
soc-2 suppressor of clear homolog (C. elegans) |
9826 |
0.14 |
chr6_163219933_163220084 | 0.41 |
PACRG |
PARK2 co-regulated |
15269 |
0.28 |
chr3_33095798_33096165 | 0.41 |
GLB1 |
galactosidase, beta 1 |
42303 |
0.12 |
chr1_100866866_100867158 | 0.41 |
ENSG00000216067 |
. |
22681 |
0.18 |
chr10_130855671_130855903 | 0.41 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
409661 |
0.01 |
chr8_81289205_81289813 | 0.41 |
ENSG00000252884 |
. |
28242 |
0.19 |
chr8_37131917_37132068 | 0.41 |
RP11-150O12.6 |
|
242547 |
0.02 |
chr2_191874328_191874547 | 0.41 |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
3876 |
0.21 |
chr5_39275310_39275719 | 0.41 |
FYB |
FYN binding protein |
884 |
0.72 |
chr8_59924673_59924824 | 0.40 |
RP11-328K2.1 |
|
19251 |
0.25 |
chr1_111176210_111176587 | 0.40 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
2302 |
0.29 |
chr4_6697224_6697376 | 0.40 |
S100P |
S100 calcium binding protein P |
2504 |
0.21 |
chr8_129556248_129556417 | 0.40 |
ENSG00000221351 |
. |
275708 |
0.01 |
chr17_34040072_34040441 | 0.40 |
RASL10B |
RAS-like, family 10, member B |
18412 |
0.11 |
chr3_71136097_71136325 | 0.40 |
FOXP1 |
forkhead box P1 |
21293 |
0.28 |
chr10_76727829_76728046 | 0.40 |
RP11-77G23.5 |
|
56072 |
0.12 |
chr1_26005320_26005471 | 0.40 |
RP1-187B23.1 |
|
19793 |
0.17 |
chr4_186185134_186185431 | 0.40 |
SNX25 |
sorting nexin 25 |
54049 |
0.11 |
chr15_64152644_64152888 | 0.40 |
ENSG00000199156 |
. |
10452 |
0.21 |
chr2_30559450_30559652 | 0.40 |
ENSG00000221377 |
. |
95763 |
0.07 |
chr9_88953538_88953925 | 0.40 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
4307 |
0.27 |
chr17_47823245_47823396 | 0.40 |
FAM117A |
family with sequence similarity 117, member A |
18173 |
0.14 |
chr17_37916952_37917103 | 0.40 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
17451 |
0.11 |
chr9_100666794_100667000 | 0.40 |
C9orf156 |
chromosome 9 open reading frame 156 |
7856 |
0.16 |
chrX_119889254_119889658 | 0.40 |
CT47B1 |
cancer/testis antigen family 47, member B1 |
120323 |
0.04 |
chr18_3059865_3060090 | 0.40 |
ENSG00000252353 |
. |
33589 |
0.13 |
chr9_92082755_92083098 | 0.40 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
11879 |
0.23 |
chr7_110736643_110736794 | 0.40 |
LRRN3 |
leucine rich repeat neuronal 3 |
5619 |
0.27 |
chr21_35468926_35469077 | 0.39 |
SLC5A3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
23131 |
0.19 |
chr9_92133489_92134097 | 0.39 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
20748 |
0.2 |
chr2_106797151_106797302 | 0.39 |
AC018878.3 |
|
1228 |
0.54 |
chr11_36472811_36473244 | 0.39 |
RP11-219O3.2 |
|
25355 |
0.17 |
chr13_52527464_52527703 | 0.39 |
ATP7B |
ATPase, Cu++ transporting, beta polypeptide |
8468 |
0.22 |
chr17_66343908_66344364 | 0.39 |
ARSG |
arylsulfatase G |
56477 |
0.1 |
chr2_135099020_135099171 | 0.39 |
MGAT5 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
87265 |
0.1 |
chr8_8731469_8731701 | 0.39 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
19570 |
0.19 |
chr1_187061554_187061705 | 0.39 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
263507 |
0.02 |
chr5_131126504_131126655 | 0.39 |
FNIP1 |
folliculin interacting protein 1 |
6035 |
0.23 |
chr2_198057877_198058189 | 0.39 |
AC013264.2 |
|
4682 |
0.23 |
chr11_114001658_114001870 | 0.39 |
ENSG00000221112 |
. |
44113 |
0.16 |
chr10_17469095_17469250 | 0.39 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
19146 |
0.17 |
chr12_4926448_4926851 | 0.39 |
KCNA6 |
potassium voltage-gated channel, shaker-related subfamily, member 6 |
8307 |
0.2 |
chr1_206738972_206739123 | 0.39 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
8554 |
0.17 |
chr17_74979048_74979216 | 0.39 |
ENSG00000267568 |
. |
13894 |
0.22 |
chr6_159486400_159486551 | 0.39 |
TAGAP |
T-cell activation RhoGTPase activating protein |
20291 |
0.18 |
chr3_112460889_112461040 | 0.39 |
ENSG00000242770 |
. |
60361 |
0.12 |
chr4_40245605_40245832 | 0.39 |
RHOH |
ras homolog family member H |
43754 |
0.15 |
chr1_6091978_6092246 | 0.39 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
2231 |
0.28 |
chr7_127054523_127055019 | 0.38 |
ZNF800 |
zinc finger protein 800 |
17207 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 1.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 1.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 1.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.3 | 0.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 1.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 1.5 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.2 | 2.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.2 | GO:0002913 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.4 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 1.2 | GO:0002837 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 1.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 1.0 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.7 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.2 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 8.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.6 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.8 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.2 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.9 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.5 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.4 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.9 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.5 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.1 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.3 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.5 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.2 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.2 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 2.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0070245 | positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.2 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0031442 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.4 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0032914 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0001743 | optic placode formation(GO:0001743) |
0.0 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.2 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0072075 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.0 | 0.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.0 | GO:0052510 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.0 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.6 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.8 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 1.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.0 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.0 | 0.2 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.0 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar cortex formation(GO:0021697) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 2.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.7 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.3 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.0 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.2 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.4 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.2 | GO:0002209 | behavioral defense response(GO:0002209) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.0 | GO:0010535 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 1.6 | GO:0000084 | mitotic S phase(GO:0000084) |
0.0 | 0.1 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.1 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.9 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 1.8 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.7 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 1.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.7 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.0 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0034443 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.4 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.8 | GO:0019080 | viral gene expression(GO:0019080) viral transcription(GO:0019083) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.6 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 2.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 2.3 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 2.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.1 | GO:0044462 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 2.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0031248 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 1.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 2.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.4 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 3.7 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 10.1 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.8 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.7 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 1.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 1.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 2.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.8 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 2.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 2.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.9 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.0 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 1.0 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.5 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 1.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 7.7 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 2.4 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 1.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 1.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 2.4 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.2 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 3.0 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.4 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 0.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 13.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 4.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 2.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 1.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 2.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 2.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |